Despite increasing knowledge on the regulation of hematopoietic stem/progenitor cell (HSPC) selfrenewal and differentiation, in vitro control of stem cell fate decisions has been difficult. The ability to inhibit HSPC commitment in culture may be of benefit to cell therapy protocols. Small molecules can serve as tools to manipulate cell fate decisions. Here, we tested two small molecules, valproic acid (VPA) and lithium (Li) to inhibit differentiation. HSPCs exposed to VPA and Li during differentiation-inducing culture preserved an immature cell phenotype, provided radioprotection to lethally irradiated recipients and enhanced in vivo repopulating potential. Anti-differentiation effects of VPA and Li were observed also at the level of committed progenitors, where VPA re-activated replating activity of CMP and GMP cells. Furthermore, VPA and Li synergistically preserved expression of stem cell-related genes and repressed genes involved in differentiation. Target genes were collectively co-regulated during normal hematopoietic differentiation. Additionally, transcription factor networks were identified as possible primary regulators. Our results demonstrate that the combination of VPA and Li potently delays differentiation at the biological and the molecular level, and provide evidence to suggest that combinatorial screening of chemical compounds may uncover possible additive/synergistic effects to modulate stem cell fate decisions.
Introduction
Hematopoietic stem/progenitor cells (HSPCs) have a great clinical potential, but many of their applications are limited by insufficient numbers. Therefore, attempts have been made to define culture conditions, which would amplify stem cells in an uncommitted state and maintain their potential in vivo [1] [2] [3] . However, so far there has been limited success in preventing HSPC commitment and differentiation in vitro without genetic manipulation (e.g. overexpression of HoxB4, Bmi1, β -catenin). [4] [5] [6] Alternatively, small molecules could be used as new tools for manipulating cell fate decisions. A number of these compounds have been identified to affect developmental processes, stem cell self-renewal and differentiation, or reprogramming efficiency of somatic cells to a pluripotent state. 3, [7] [8] [9] [10] [11] Two of such molecules, valproic acid (VPA) and lithium (Li), have been shown to affect normal and malignant hematopoiesis. 12, 13 Valproic acid is a pleiotropic histone deacetylase (HDAC) inhibitor (HDI), which can modulate histone acetylation by preventing its deacetylation. 8 During commitment and differentiation, the chromatin structure of stem cells undergoes major epigenetic changes, which affect cellular transcriptional programs. Therefore, factors interfering with chromatin remodeling enzymes, such as HDIs, might modulate the behavior of stem and progenitor cells. 14, 15 For instance, it has been recently suggested that VPA can enhance stem cell proliferation, while retaining selfrenewal in ex vivo stem cell expansion protocols. [16] [17] [18] Furthermore, several groups suggested that
HDIs can affect multilineage differentiation of hematopoietic cells. [19] [20] [21] [22] The hematopoietic effects of lithium have been described for the first time in psychiatric patients, which included disturbed differentiation into several lineages and increased numbers of CD34 + cells. 13, 23, 24 In vivo and in vitro studies with human and murine bone marrow cells confirmed the stimulatory effects of Li on hematopoiesis. 25, 26 Furthermore, experimental findings suggest that Li can increase transplantable
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From 4 HSPCs in mice. 25 Although the mechanism by which Li affects HSPC is unclear, multiple molecular targets have been proposed, including GSK-3β, a negative regulator of Wnt pathway. 27 Wnt signaling, as well as epigenetic events play an important role in control of HSPC fate decisions. 6, 14 Taken together, data suggest that VPA and Li might serve as chemical regulators of both stem cell maintenance and differentiation.
We hypothesized that combinations of small molecules might be useful to promote maintenance of HSPC in culture by inhibiting cell commitment. In this study, the combined effects of VPA and Li on HSPC proliferation, differentiation and self-renewal were investigated. We document potent synergistic effects of both chemical compounds in a variety of in vitro and in vivo assays and showed strong anti-differentiation activity at the level of uncommitted and committed progenitors. Moreover, we identified genetic networks and putative targets that are transcriptionally affected by both compounds. Our data support the notion that chemical compounds may be of use in ex vivo cell therapy protocols.
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Material and Methods

Mice
Female B6.SJL (CD45.1) mice, originally purchased from Jackson Laboratory (Bar Harbor, USA) and bred in our local animal facility, and female wild type B6 (CD45.2) mice (Harlan, Horst, NL) were used as a source of donor HSPCs. In the transplantation settings, we used female B6.SJL donors, female wild type B6 (Harlan) bone marrow as competitors and female F1:B6xB6.SJL (CD45.1/2) as recipients. All animal experiments were approved by the local animal ethical committee of the University of Groningen.
Stem/progenitor cell isolation
Mice were anaesthetized and sacrificed by cervical dislocation. Unfractionated bone marrow cells were obtained by crushing femora, tibia and pelvic bones. Cell suspensions were filtered through a 100 µm cell strainer (BD Biosciences, San Diego, CA) to remove debris and the cells were counted on a Medonic CA620 analyzer (A.Menarini Diagnostics, Valkenswaard, NL). Following erythrocyte lysis cells were stained with lineage cocktail (A700-Mac1, A700-Gr1, A700-Ter119, A700-CD3, A700-B220), Pacific Blue-Sca1, PE-ckit, FITC-CD34 and PECy7-CD16/32 (Biolegend, San Diego, CA). Following staining, the cells were resuspended in propidium iodide (PI) solution (1µg/ml) and 
Stem/progenitor cell differentiation
Freshly isolated uncommitted and committed hematopoietic progenitor subpopulations were differentiated in a liquid or semisolid medium in the presence of fetal calf serum (10% or 30% FCS, respectively), murine stem cell factor (100ng/ml) (mSCF, Amgen, Thousand Oaks, CA) and recombinant murine granulocyte/macrophage-colony stimulating factor (10ng/ml or 20ng/ml respectively) (mGM-CSF, R&D Systems, Abingdon, UK). Cells in liquid cultures were plated at a density of 2000 cell/ml in a 6-well plate (Costar, NY, USA) and cultured in StemSpan medium (Stem Cell Technologies, Vancouver, Canada). Cells in semisolid medium were plated in various concentrations. The cells were cultured for 7 days at 37°C in a humidified atmosphere and 5% CO 2 in air (Stem Cell Technologies, Vancouver, CA) with or without 1mM VPA (Sigma, St.Louis, MO, USA) or 5mM LiCl (J.T.Baker, Phillipsburg, USA), or the combination. Both compounds were dissolved in PBS solution (PAA Laboratories GmbH, Passching, Austria).
Cell analysis
Following liquid cultures, cells were harvested and total cell number and cell viability was determined by trypan blue and/or PI exclusion. Cultured cells were centrifuged for cytospin preparations (800 RPM, Shandon cytospin III cytocentrifuge, Thermo Fisher Scientific BV, Breda, NL) and stained with May-Grünwald-Giemsa staining. Cytospins were analyzed using light 
Clonogenic assays
The colony forming unit assay was performed to assess the potential of cells to form granulocyte/macrophage colonies (CFU-GM). Briefly, either freshly isolated hematopoietic progenitor subpopulations or cells differentiated for 7 days were plated in a methylcellulose medium, and after 6 or 7 days colonies with granuloid and/or macrophage cells were scored. Colonies derived from single cells of freshly isolated progenitors were replated and secondary GM colonies were scored after another 7 days of semisolid culture. To assess the number of hematopoietic progenitor cells or more primitive stem cells cobblestone area forming cell (CAFC) assays were performed in the population of 7-day differentiated cells. Both assays were performed as described previously. 
Gene expression analysis
Global gene expression was assessed in 7-day cultured cells (GF only, Li, VPA, Li+VPA). All samples were analyzed in independent biological triplicates. Total RNA was isolated using the RNeasy kit (Qiagen), according to manufacturer's protocol. RNA concentration, quality and and extraction of raw expression data were performed using BeadStudio software (Illumina) with default settings, no background subtraction and no normalization. The raw data were thresholded at 1, log2-transformed and quantile normalized using GeneSpring-GX11.0 (Agilent). From the starting probe list (25.697 probes) probes not expressed in any replicate of the 4 conditions were excluded.
The filtered list represented 20.586 probes. Probes differentially expressed between drug-treated and control sample (GFs only) were defined by Welch t-test with Benjamini-Hochberg correction and false discovery rate <0.05. Next, a 1.5-fold differential expression cut-off was applied. Gene expression analyses of 4 distinct primary cell subsets (LSK, L-S-K+, Gr1+, Ter119+) as described previously 29 , were used for comparison of VPA and Li effects with the physiological hematopoietic differentiation program. Finally, data was subjected to relevance network analyses as described in Voy at al. 30 Networks were visualized in Gephi software using Yifan-Hu and Fruchterman-Reingold force-directed layout algorithm. 31 All raw data were deposited in the NCBI Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/), accession numbers GSE34088.
Chromatin immunoprecipitation (ChIP) assay
The ChIP assay was performed to determine histone acetylation at promoter regions of specific genes using the method described by Frank et al. 32 In brief, 5x10 6 cells were fixed with 1%
formaldehyde for 10min at RT. Following cell lysis, cross-linked chromatin was fragmented by sonication to obtain ∼200-600bp fragments. Pre-cleared chromatin was precipitated with anti-acetyl- 
Enhanced in vitro functional potential of cells exposed to VPA and Lithium
To test whether cells exposed to VPA and Li retained stem/progenitor function, in vitro assays for hematopoietic cell activity were performed. Progenitor potential of 7-day cultured cells was determined using semisolid colony-forming unit assay, where cells were stimulated into granulocyte/macrophage colonies with GM-CSF and SCF. Cells treated with VPA alone or with a combination of VPA+Li gave rise to a higher number of colonies than control cells (45-fold and 81-fold more, respectively). However, treatment with Li did not significantly influence colony forming capacity ( Fig. 2A) . To test the functional activity of more primitive cells after 7 days of differentiation culture, we performed cobblestone area forming cell assays (CAFC). In this assay progenitor activity is measured by early appearing CAFC (day-7) and stem cell activity by late appearing CAFC (day-35). Cells exposed to the combination of both compounds (VPA+Li) showed a 30-fold increase in absolute numbers of early-and a 3.5-fold increase in absolute numbers of lateappearing CAFC (p<0.05) compared to control cells (GFs only). Cells treated with VPA alone showed 7-fold and 2-fold more early and late CAFC activity (p<0.05), respectively. In contrast, for Li-treated cells no enhancement of early or late CAFC activity was observed (Fig. 2B) . As shown by these two independent assays, the in vitro functional potential of stem and progenitor cells was significantly enhanced by VPA and VPA+Li treatment, but combination of both compounds most efficiently preserved HSPC function.
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VPA and Lithium improve survival, blood cell recovery and short-time engraftment after BM transplant
In order to confirm the functional activity observed using in vitro assays, the in vivo reconstitution properties of cells differentiated in the presence of VPA and/or Li were examined. The progeny of 2000 LSK cells, cultured for 7 days with GM-CSF with or without VPA and Li, was transplanted into lethally irradiated mice. At day 10, 14, 21, 28 and 32 post-transplantation survival and recovery of peripheral blood counts were analyzed. Mice transplanted with cells exposed to VPA+Li had significantly (p<0.05) improved survival (12/14 mice survived) compared to control mice which received cells cultured with GFs only (6/14 mice survived) (Fig. 3A) . In addition, blood cell counts revealed that the red blood cell numbers and platelet numbers recovered faster in recipients transplanted with VPA+Li-treated cells compared to control mice, confirming more progenitor cell activity in the transplanted cell population (Fig. 3B-C) . In contrast, mice reconstituted with cells cultured in the presence of a single drug, either VPA or Li, did not show improved survival or blood recovery over mice transplanted with cells differentiated with GFs only (supplementary Fig. S1 ). These data strongly indicate that the combination of VPA+Li most potently preserved immature, radioprotective hematopoietic progenitor cells.
To evaluate the effects of VPA+Li treatment on long-term repopulating capacity, the cultured progeny of 2000 LSK cells was transplanted into lethally irradiated recipients together with freshly isolated bone marrow competitor cells. Recipient mice transplanted with cells cultured in the presence of VPA+Li displayed higher chimerism levels through the entire time-course of the experiment compared to mice transplanted with cells cultured in the presence of GFs only. However, the differences between the two groups decreased over time. (Fig. 3D) The percentage of chimerism was significantly higher in VPA+Li group up to 13 weeks post-transplantation, suggesting robust Fig. S1 ). Additionally, treatment with VPA+Li did not influence the multilineage capacity of the cells since all mature blood types were found in comparable ratios (supplementary Fig. S1 ). Collectively, these data strongly indicate that addition of VPA+Li to differentiation-inducting cultures preserved cells with in vivo repopulation potential.
VPA increases proliferation and self-renewal of committed myeloid progenitors
Since our results indicate that VPA and Li enhanced short-term repopulating progenitor cells, the effects of the compound treatment on distinct progenitor cell subsets were characterized. To address this question we isolated by flow cytometry uncommitted (LSK) and committed myeloid (CMP and GMP) cell subsets and performed methylcellulose assays for each sorted cell population (Fig.4A ). Cells were stimulated to differentiate with SCF and GM-CSF in the presence of VPA and/or Li. VPA and VPA+Li decreased colony forming activity of LSK cells, showed no effect on clonogenic activity of CMP cells, but displayed strong potentiating effect on colony forming ability of the GMP cell population (Fig. 4A ). GMPs had a limited colony forming ability (~ 40 colonies per 1000 cells), which increased in the presence of VPA and VPA+Li by almost 8-fold. Li, as a single agent, showed no effect on colony forming ability of the tested progenitor cell populations.
To investigate whether the observed effects on clonogenic activity were caused by either proliferation or cell death (or both), single cell proliferation assay was performed. Single cells of each distinct progenitor population (LSK, CMP, GMP) were sorted into 96-well plates in liquid Less than 40% of GMPs at the single cell level were able to grow into medium or large colonies, whereas upon addition of VPA and VPA+Li more than 80% of colonies grow into larger (medium+large) colonies. The enhancing effect of VPA and VPA+Li on cell proliferation was also apparent at the level of CMPs, however to a lesser extent. Surprisingly, VPA and VPA+Li decreased proliferative capacity of the LSK cells. At the single cell level Li alone showed no effects on the proliferation of distinct hematopoietic cell populations. (Fig.4B ). These data indicate that VPA displayed a major effect on cell proliferation, which was potentiated in the presence of Li.
Next, the effect of VPA treatment on plating efficiency of distinct cell progenitor populations was tested using single cell colony-forming unit assay. Single cells of each of the 3 progenitor populations were sorted into 96-well plate in semisolid medium with SCF and GM-CSF and cultured with or without VPA and/or Li. VPA and VPA+Li decreased the plating efficiency of LSK cells, did not influence CMP plating efficiency, but significantly increased the plating efficiency of GMP at the single cell level (in accordance with Fig.4A ). Strikingly, whereas ~10% of purified GMP were able to produce colonies in the presence of GFs only, the addition of VPA or VPA+Li increased clonogenic activity of GMP to 60% (Fig.4C) . Next, the self-renewal potential of compound-exposed cells was determined by replating colonies derived from a single cell. From each group, approximately 30 individual colonies were harvested and replated to new methylcellulose cultures in the presence or absence of VPA and/or Li. In the presence of GF only ~50% of individual colonies formed by single LSK cells were able to generate secondary colonies, whereas upon exposure to
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VPA and VPA+Li 100% of the replated colonies derived from single LSK cells gave rise to secondary colonies. Furthermore, VPA and VPA+Li not only enhanced LSK replating efficiency of individual colonies, but also increased the total number of secondary colonies derived from a single cell. Strikingly, while CMP and GMP cells did not show any replating activity by themselves, addition of VPA and VPA+Li induced replating activity of these progenitor populations resulting in ~60% and ~35% of secondary colonies, respectively. Addition of Li to primary or secondary single cell cultures did not affect cell (re-)plating efficiencies (Fig.4D) .
Summarizing, the effect of VPA or the combination of VPA+Li on colony forming ability varied depending on the differentiation status of the cell. VPA and VPA+Li inhibited proliferation and colony forming ability of LSK cells, but increased its self-renewal potential measured by replating. Whereas proliferation and clonogenic activity of CMPs were not significantly influenced, VPA and VPA+Li induced replating capacity of this population. GMPs were specifically sensitive to VPA or the combination treatment, since the compounds not only strongly increased clonogenic activity, plating efficiency and proliferation of this population, but also induced their self-renewal capacity.
VPA and Lithium synergistically preserve HSPC gene expression profile
To identify molecular events by which VPA and/or Li are able to inhibit differentiation, we performed expression arrays on 7-day differentiated LSK cells in the presence or absence of VPA with or without Li. RNA samples were harvested at the time point when in vitro and in vivo assays were initiated. Differential expression analyses (for details see materials and methods) revealed very distinct effects of Li and VPA on gene expression. Whereas no differentially expressed genes could be identified upon Li treatment compared to GFs only (Fig.5A) , VPA significantly affected 60
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From genes, of which 10 were upregulated and 50 downregulated. Strikingly, an obvious more than additive effect was observed when Li was added to VPA in our differentiation cultures. The combined treatment of VPA+Li resulted in differential expression of 360 genes (110 upregulated and 250 downregulated), revealing a strong synergistic effect (Fig. 5A) . The lists of all genes differentially expressed upon the compounds treatment is presented in Table S1 .
To assess whether VPA+Li treatment inhibited differentiation by preserving a primitive cell transcriptome, the changes in expression of VPA+Li targets (identified above) were compared to normal hematopoietic differentiation. For this purpose, previously obtained transcriptome data of 4 developmentally distinct hematopoietic cell stages, stem cells (Lin-Sca1+ckit+), progenitors (LinSca1-ckit+), myeloid (Gr1+) and erythroid (Ter119+) cells, were used. 29 Analysis revealed that target genes that were upregulated by VPA+Li were more abundantly expressed in primary stem/ progenitor cells compared to differentiated myeloid and erythroid cells, whereas VPA+Li downregulated targets showed the opposite pattern, being higher expressed in differentiated than in uncommitted cells. (Fig. 5B) Since VPA+Li treatment altered expression of 360 genes, an important question is whether expression changes of these targets are all independent or co-regulated. Cellular differentiation is most likely orchestrated by networks of co-regulated genes, rather than by changes in expression of individual genes. To address this question, the method described in detail by Voy et al was used. 30 First, gene correlation studies (using Pearson coefficient) were performed using the same transcriptome data of the 4 developmentally distinct hematopoietic cell stages as used for determining cell type expression abundance of VPA+Li affected targets (described above). The strongest correlations, most likely reflecting biological relevance, were defined by <-0.8 or >0.85 thresholds and visualized using Gephi software. 31 Such a gene relevance network, reflecting
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From similarity measures of gene expressions in 4 cell populations, is presented in figure 5C . VPA+Li targets were color-coded according to the expression abundance. Interestingly, it appeared that VPA+Li targets are co-regulated during normal hematopoietic differentiation, creating high connectivity networks. Additionally, genes clustered together according to a specific cell type, creating a network consisting of 3 apparent clusters. One combined cluster contained genes most abundantly expressed in either stem (green) or progenitor (yellow) cells, and two separate clusters contained genes predominantly expressed in myeloid (blue) or erythroid (purple) cells (Fig. 5C ).
Network analysis revealed also differential gene induction or repression by the treatment. As expected, genes within a cluster, usually expressed in the same cell type, showed positive correlations (red lines) with each other, suggesting that expression levels of these genes are changed in parallel by VPA+Li. However, strong negative correlations (blue lines) were apparent between genes belonging to separate clusters. Almost all genes within the stem/progenitor cluster displayed inverse correlation with genes within myeloid and erythroid clusters, indicating interesting gene relationships between uncommitted and differentiated cells. Collectively, our analyses show that VPA+Li affected the differentiation program of the cell by perturbing the coordinated expression of multiple genes in co-regulated fashion, preserving stem/progenitor genes and downregulating differentiation-associated genes.
In order to try to identify primary candidates likely involved in cell fate decisions, the VPA+Li target list was filtered for transcription factors (TFs) and other DNA and RNA interacting genes. Table 1 provides a full list of transcriptional regulators that were affected by the treatment. A reduced network retained the 3-cluster structure with strong negative correlations between stem/progenitor and differentiated-cell associated TFs. (Fig. 5D) . Among VPA+Li upregulated targets were several known stem/progenitor TFs, such as Gata2, Gfi-1 and HoxA7. [33] [34] [35] Other TFs,
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From with still unknown functions in HSC, could also be assigned to the stem cell cluster, including Rbbp7 and Phf5. Moreover, TFs involved in epigenetic events, such as Hmgn3 and Prmt5 were upregulated by the VPA+Li treatment. 36 In contrast, the majority of the downregulated targets were correlated with cellular differentiation, including known TFs for myeloid (Erg1/2, Junb) 37, 38 , erythroid/megakaryocyte (Dab2) 39 and lymphoid (Irf5, Nfkbia) 40, 41 differentiation. TFs upregulated by the treatment, showing a negative correlation with differentiation-associated TFs, seem to be especially interesting as targets for differentiation-preventing agents.
Since VPA is an epigenetic modifier, known to affect gene expression by preventing chromatin deacetylation, we tested whether the observed changes in gene expression were caused by altered histone acetylation levels. To this end, chromatin immunoprecipitation assays (ChIP) using antibodies against acetylated histone H4 were performed. As proof of principle, HoxA7, upregulated by both VPA and VPA+Li, was selected for ChIP assay. Interestingly, several reports have suggested that another homeobox gene, HoxB4 is a target of VPA in human cells. [16] [17] [18] In our study 
Discussion
To date, attempts to define culture conditions that would favor stem cell self-renewal over differentiation have resulted in limited success. We hypothesized that combinations of cytokines and small molecules might represent an integrative approach to prevent differentiation in culture. In this report, we tested the combination of a well known HDI, valproic acid, with the simple cation, lithium, on HSPC maintenance under strong differentiation pressure and showed that the combination of these two compounds displayed strong anti-differentiation effects on hematopoietic differentiation at the biological and the molecular level. Whereas Li as a single agent displayed very limited effects on HSPC differentiation, VPA and the combination of VPA+Li were able to preserve in vitro functionality of LSK and induced self-renewal of committed progenitors (CMPs and GMPs).
Strikingly, after a 7-day differentiation culture only the combination of these two agents provided radioprotection to lethally irradiated recipients, shortened the time required for platelet and red blood cell recovery, and enhanced in vivo repopulation potential. These observations are consistent with previous reports suggesting that VPA or Li, can affect fate decision of HSPC 16-18, 20-22, 25, 26 , but to our knowledge this is the first report showing that VPA+Li act synergistically to delay HSPC differentiation.
In accordance with the biological data, the most compelling evidence that VPA+Li act synergistically to inhibit LSK differentiation was provided by genome-wide gene expression analysis. Strikingly, VPA+Li affected expression of 360 genes, whereas VPA alone affected only 60 genes and lithium did not affect any genes. Network analysis provided evidence that most genes affected by VPA+Li were co-regulated during normal hematopoietic differentiation. In addition, VPA+Li preserved expression of stem cell-related genes, which coincided with repression of genes involved in differentiation. This indicates that the anti-differentiation effects of VPA+Li are caused
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by coordinated changes in multiple co-regulated genes, rather than in individual genes. Our findings were further illustrated by the fact that TFs (likely being the primary targets in the network) favoring self-renewal (e.g. Gata2, Gfi-1, HoxA7) [33] [34] [35] were increased and differentiation-associated TFs were decreased upon VPA+Li treatment. Recently, it has been suggested that competition and balance between TFs, such as Gata2, PU.1, Gfi-1, Erg1/2, may regulate switches between self-renewal and differentiation, and triggers the determination of cell fate. 3, 37, [42] [43] [44] The inhibition of the differentiation program was shown for multipotent uncommitted and also for committed cells, which are at various stages of differentiation. Strikingly, upon addition of VPA and VPA+Li, individual CMP and GMP progenitor cells re-acquired replating capacity in methylcellulose assays, suggesting possible cellular de-differentiation. However, whether the same mechanism is responsible for the effects of Li+VPA on committed progenitor-vs LSK-differentiation remains to be determined.
The balance between histone acetylation and deacetylation is thought to play an important role in maintaining chromatin structure consistent with the stem cell state. Epigenetic regulation is believed to be important for cell fate decision and epigenetic transcriptional repression was suggested to be required for silencing of stem cell genes and subsequent cell differentiation. 14, 15, 44 Valproic acid has been shown to inhibit HDACs and therefore could interfere with the epigenetic status of the cell. 8 We confirmed increased histone acetylation at the HoxA7 promotor region correlating with the increased expression of HoxA7. In addition, other confirmed VPA+Li targets (Gata2) have been suggested to bind to HDAC or to be involved in epigenetic modifications (Hmgn3, Prmt5). 36, 45 Moreover, the chromatin conformation maintained by VPA might allow a spectrum of Li targets to be better accessible. Thus, common targets of VPA and Li (e.g. Wnt pathway) 46 in combination with more accessible chromatin conformation may result in the observed synergistic effect of these two compounds. Therefore, modulation of epigenetic regulation of gene Methods to inhibit stem cell differentiation may be of benefit in ex vivo cell therapy protocols, which would favor in vitro HSPC self-renewal rather than commitment and differentiation. So far, culturing systems with "classical" hematopoietic GFs resulted in stem cell loss due to profound differentiation. 
